These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32616185)

  • 1. Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I.
    Montgomery AP; Dobie C; Szabo R; Hallam L; Ranson M; Yu H; Skropeta D
    Bioorg Med Chem; 2020 Jul; 28(14):115561. PubMed ID: 32616185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of α-Hydroxy-1,2,3-Triazole-linked Sialyltransferase Inhibitors and Evaluation of Selectivity Towards ST3GAL1, ST6GAL1 and ST8SIA2.
    Szabo R; Dobie C; Montgomery AP; Steele H; Yu H; Skropeta D
    ChemMedChem; 2024 Aug; 19(16):e202400088. PubMed ID: 38758134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational characterisation of the interactions between human ST6Gal I and transition-state analogue inhibitors: insights for inhibitor design.
    Montgomery A; Szabo R; Skropeta D; Yu H
    J Mol Recognit; 2016 May; 29(5):210-22. PubMed ID: 26669681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation.
    Montgomery AP; Skropeta D; Yu H
    Sci Rep; 2017 Oct; 7(1):14428. PubMed ID: 29089525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided design of human sialyltransferase inhibitors of hST8Sia III.
    Dobie C; Montgomery AP; Szabo R; Skropeta D; Yu H
    J Mol Recognit; 2018 Feb; 31(2):. PubMed ID: 29119617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Substituted Cyclopentane-CMP Conjugates as Potent Sialyltransferase Inhibitors.
    Li W; Niu Y; Xiong DC; Cao X; Ye XS
    J Med Chem; 2015 Oct; 58(20):7972-90. PubMed ID: 26406919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of flavonoids as sialyltransferase inhibitors.
    Hidari KI; Oyama K; Ito G; Nakayama M; Inai M; Goto S; Kanai Y; Watanabe K; Yoshida K; Furuta T; Kan T; Suzuki T
    Biochem Biophys Res Commun; 2009 May; 382(3):609-13. PubMed ID: 19303395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Preliminary Evaluation of Biological Activity of Glycoconjugates Analogues of Acyclic Uridine Derivatives.
    Komor R; Pastuch-Gawolek G; Krol E; Szeja W
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30104510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancement of Sialyltransferase Inhibitors: Therapeutic Challenges and Opportunities.
    Szabo R; Skropeta D
    Med Res Rev; 2017 Mar; 37(2):219-270. PubMed ID: 27678392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialyltransferase inhibition and recent advances.
    Wang L; Liu Y; Wu L; Sun XL
    Biochim Biophys Acta; 2016 Jan; 1864(1):143-53. PubMed ID: 26192491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of sialyltransferases: potential roles in tumor growth and metastasis.
    Drinnan NB; Halliday J; Ramsdale T
    Mini Rev Med Chem; 2003 Sep; 3(6):501-17. PubMed ID: 12871154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of phosphoramidate amino acid-based inhibitors of sialyltransferases.
    Whalen LJ; McEvoy KA; Halcomb RL
    Bioorg Med Chem Lett; 2003 Jan; 13(2):301-4. PubMed ID: 12482445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities.
    Izumi M; Wada K; Yuasa H; Hashimoto H
    J Org Chem; 2005 Oct; 70(22):8817-24. PubMed ID: 16238314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.
    Higgins C; Bouazzaoui S; Gaddale K; D'Costa Z; Templeman A; O'Rourke M; Young A; Scott C; Harrison T; Mullan P; Williams R
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2521-4. PubMed ID: 24775305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study.
    Perez SJLP; Chen CL; Chang TT; Li WS
    Bioorg Med Chem Lett; 2024 Jun; 105():129760. PubMed ID: 38641151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitors.
    Vincent F; Nguyen MT; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6793-6. PubMed ID: 19850474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncharged nucleoside inhibitors of β-1,4-galactosyltransferase with activity in cells.
    Jiang J; Kanabar V; Padilla B; Man F; Pitchford SC; Page CP; Wagner GK
    Chem Commun (Camb); 2016 Mar; 52(20):3955-8. PubMed ID: 26882174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: Current Challenges and Future Perspectives.
    Perez SJLP; Fu CW; Li WS
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues.
    Skropeta D; Schwörer R; Haag T; Schmidt RR
    Glycoconj J; 2004; 21(5):205-19. PubMed ID: 15486453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential sialyltransferase inhibitors based on neuraminyl substitution by hetaryl rings.
    Mathew B; Schmidt RR
    Carbohydr Res; 2007 Feb; 342(3-4):558-66. PubMed ID: 16989791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.